MICA · FIRST-LINE LEARNING NOTES
Understand, prioritise and organise follow-up
Screening concerns people without symptoms of the target condition. It requires a pathway for diagnostic confirmation and treatment, with balanced information about benefit and limitations.
Distinguish screening from diagnosis
A symptom, mass, bleeding or unexplained decline requires diagnostic assessment even after a recent negative screening result. Testing an asymptomatic person requires an appropriate target population and evidence of benefit. Systematic panels or reassurance-driven tests do not replace history and examination.
[1][2]Check eligibility and context
Review age, personal and family history, previous tests and any condition-specific surveillance. High-risk patients may need a different pathway from the general population. In Algeria, verify current national programmes and local arrangements. The cited European recommendations are an international example; their ages, tests and intervals should not be attributed to Algerian programmes.
[3][2]Screening concerns people without suggestive symptoms; symptoms or warning signs require diagnostic assessment even after a recent negative screen. Discuss expected benefit, false positives, false negatives and overdiagnosis. Suitability depends on individual risk and a pathway capable of providing confirmation and subsequent treatment.
[2][3]Support a balanced decision
Explain the target condition, procedure and possible next steps. A positive screen does not automatically mean cancer; a negative result does not permanently exclude disease. Discuss false results, complications and overdiagnosis, including lesions that would never have caused symptoms. Use accessible information and respect an informed choice. Confirmation and treatment capacity matter as much as access to the initial test.
[2][3]Ensure follow-up after testing
Record the offer, result and required next step. Positive screens need an identified diagnostic pathway and responsible clinician, not simply advice to seek another appointment. Track completion and feedback. After a negative test, explain that new symptoms still require assessment. Reassess surveillance if a relevant history or familial risk emerges.
[1][3]A learning situation
FICTIONAL CASE · SELF-REFLECTION WITHOUT A SCORE
A person recently received a negative screening result but now has persistent bleeding. They assume they can wait for the next invitation. Relatives suggest repeating the same screening test instead.
Does the earlier result justify delaying assessment?
References and scope
- Guide to cancer early diagnosis ↗
- Cancer — Screening and early detection ↗
- Council updates its recommendation to screen for cancer ↗
Original educational synthesis for adult first-line practice. International references must be interpreted with the clinical setting and local care pathways. Independent human scientific review remains to be confirmed.